Business Context and Reporting Period
Company: The Chemours Company
Filing Type: Form 8-K (Current Report)
Date of Report: September 9, 2026
Event: Regulation FD Disclosure regarding the posting of an investor presentation on the company's website for use in upcoming meetings with investors and analysts.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of an investor presentation (Exhibit 99.1) and does not contain audited or unaudited financial statements within the body of the document.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing is procedural, intended to satisfy disclosure obligations for the release of forward-looking information contained in the attached presentation.
Guidance, Outlook, and Risks
Management Commentary: The company indicated the presentation will be used for upcoming investor and analyst meetings.
Legal Disclaimer: The information furnished, including the presentation, is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Risks/Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (September 2026 Investor Presentation) for actual financial data, guidance, and strategic updates.
- Verify the content of the presentation against the company's official Investor Relations website.
- Note that the 8-K itself contains no financial figures; all quantitative data resides in the attached exhibit.